Overall Status

Completed (16)

Recruiting (15)

Active, not recruiting (10)

Terminated (8)

Enrolling by invitation (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (18)

phase 1 (13)

phase 1/phase 2 (8)

phase 3 (5)

early phase 1 (2)

n/a (1)

phase 2/phase 3 (1)

Study Documents

Intervention Type

drug (42)

other (7)

biological (6)

combination product (1)

procedure (1)

Funder Type

Industry (32)

Other (19)

Study Type

Interventional (48)

Observational (2)

Observational [Patient Registry] (1)

mantle cell lymphoma

Showing NaN - NaN of 51

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Mantle Cell Lymphoma Trial in Chicago, New York, Philadelphia (Iodine-131 Anti-B1 Antibody, Cyclophosphamide, Doxorubicin,

Completed

Mantle Cell Lymphoma

Iodine-131 Anti-B1 Antibody
Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP)

Chicago, Illinois
+2 more

Jun 23, 2005